Literature DB >> 16178947

Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey.

Joshua W Devine1, Joel F Farley, Ronald S Hadsall.   

Abstract

OBJECTIVE: The primary objectives were to examine national trends of prescription medication use for headache and explore patterns of variation in the use of these medications across social and demographic levels.
BACKGROUND: Despite widespread use of prescription medication for management of headache, little is known about utilization patterns or patient characteristics associated with receiving this type of treatment.
METHODS: This study conducted a secondary analysis of data obtained during the 2000 Medical Expenditure Panel Survey, a representative survey of the U.S. noninstitutionalized population. Weighted descriptive statistics and logistic regression models were used to evaluate patterns and rates of overall prescription medication use in patients reporting headache as a household condition.
RESULTS: An estimated 9.7 million people 18 years or older reported suffering from headache in 2000. Of these, 46% reported using at least one medication for the treatment of headache. Migraine-specific abortive medication (ie, selective serotonin receptor agonists and ergotamine derivatives) was the most frequently reported medication class, used by 36% of participants. Opiate analgesics and butalbital-containing products also experienced extensive prescribing reported by 22% and 17% of survey respondents, respectively. After adjustment for covariates, wide variation in the use of prescription medication was observed across sociodemographic characteristics including age, ethnicity, and insurance status.
CONCLUSION: The observed variation in prescription medication use by drug class and sociodemographic characteristics suggests strategies are needed for improving current prescribing patterns in this patient population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178947     DOI: 10.1111/j.1526-4610.2005.00240.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  5 in total

1.  Didactic migraine education in US doctor of pharmacy programs.

Authors:  Richard G Wenzel; Rosalyn S Padiyara; Jon C Schommer
Journal:  Am J Pharm Educ       Date:  2010-02-10       Impact factor: 2.047

Review 2.  Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis.

Authors:  Jeffrey L Jackson; Josephine M Mancuso; Sarah Nickoloff; Rebecca Bernstein; Cynthia Kay
Journal:  J Gen Intern Med       Date:  2017-07-18       Impact factor: 5.128

3.  Validation of criterion-based patient assignment and treatment effectiveness of a multidisciplinary modularized managed care program for headache.

Authors:  Thomas-Martin Wallasch; Christiane Hermann
Journal:  J Headache Pain       Date:  2012-05-13       Impact factor: 7.277

4.  Underdiagnosis of primary headaches: results of a survey on patients attending headache centres.

Authors:  N Massetto; C Gambini; P Bernardoni; E Ferrante; C Lovati; F Moschiano; M C Tonini; G Bussone; Domenico D'Amico
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

5.  Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study.

Authors:  Thomas-Martin Wallasch; Peter Kropp
Journal:  J Headache Pain       Date:  2012-07-12       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.